Cutler Group LP Bicycle Therapeutics PLC Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 07, 2023	SELL	$19.9 - $26.25 $51,739 - $68,250	-2,600 Reduced 76.47%	800 $8,000
Q2 2023 Jul 18, 2023	BUY	$18.95 - $28.67 $36,005 - $54,473	1,900 Added 126.67%	3,400 $12,000
Q1 2023 May 01, 2023	BUY	$20.02 - $31.37 $14,014 - $21,959	700 Added 87.5%	1,500 $12,000
Q4 2022 Feb 07, 2023	BUY	$20.37 - $32.9 $16,296 - $26,320	800 New	800 $7,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.